1 results match your criteria: "Oxford Centre for Diabetes and Metabolism[Affiliation]"
Diabetes Res Clin Pract
July 2003
Diabetes Trials Unit, Oxford Centre for Diabetes and Metabolism, Churchill Site, Old Road, Headington, Oxford OX3, UK.
Type 2 diabetes increases the risk of coronary heart disease (CHD) 2-4-fold, making CHD the predominant cause of death in patients with diabetes. Currently identified risk factors include, among others, hyperglycaemia, hypertension and dyslipidaemia. Since studies show that intensive glycaemic control alone will not overcome the excess CHD risk, reducing blood pressure by any means and lipid levels by using statins and fibrates is effective in reducing CHD and associated mortality in patients with type 2 diabetes.
View Article and Find Full Text PDF